Related Experiment Video
Updated: Aug 10, 2026
06:08
Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments
Published on: May 26, 2019
Dose, effect severity, and imparted energy in assessing biological effects
1Brookhaven National Laboratory, Medical Department, Upton, New York 11973-5000, USA.
Stem Cells (Dayton, Ohio)
|May 1, 1995
Summary
In cancer studies, absorbed dose is often overemphasized. Medical diagnosis and prognosis rely more on the severity of organ damage than on radiation dose, especially for low-level exposures.
Area of Science:
- Radioepidemiology
- Medical Physics
- Oncology
Background:
- Radioepidemiological studies often assign absorbed dose values to individuals, creating a perception of dose's essential role in cancer diagnosis and prognosis.
- Current radiation quantities and units, developed for acute high-dose effects in radiotherapy, are applied to low-level irradiation in cancer epidemiology without modification.
- This approach overlooks the fundamental differences in biological responses between high-dose and low-dose radiation exposures.
Purpose of the Study:
- To demonstrate that absorbed dose plays a limited role in medical diagnosis and prognosis, even in deterministic applications.
- To emphasize that medical assessments are based on the severity of organ damage rather than solely on dose.
- To reframe the use of biological indicators from 'biological dosimeters' to quantitative measures of effect severity.
Main Methods:
- Conceptual analysis of the role of absorbed dose in medical diagnosis and prognosis.
- Critique of the application of existing radiation units and quantities to low-level exposure scenarios.
- Discussion on the utility of biological indicators in assessing disease severity.
Main Results:
- Medical diagnosis and prognosis are primarily determined by the severity of organ damage, not by absorbed dose.
- Viewing biological effects (e.g., cell abnormalities) as a 'biological dosimeter' is a misapplication; they are direct measures of effect severity.
- The current methodology is considered a step backward in accurately assessing medical conditions.
Conclusions:
- Absorbed dose has a limited role in medical diagnosis and prognosis, particularly in the context of low-level radiation exposure.
- The severity of organ damage is the critical factor for medical assessment, not the radiation dose itself.
- Biological indicators are most valuable for quantifying the severity of noncancerous conditions and predicting outcomes like organ failure.
Related Concept Videos
02:59Biological Effects of Radiation
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
01:03Dose-Response Relationship: Overview
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
01:22Dose-Response Relationship: Potency and Efficacy
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
01:21Dose Size and Dosing Frequency: Determination Methods
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
01:23Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship
Pharmacodynamics explores the relationship between drug concentration and its effect. In a quantal response drug, the duration of action better correlates with drug concentration, while for graded effect drugs, the intensity of response is more relevant. This intensity depends on the dose, drug removal rate, and the region of the concentration–response curve.The concentration–response curve can be divided into three regions. Region 3 (80–100% maximum response) demonstrates that even as drug...
01:21Dose Response Curve: Conventional Versus Nonmonotonic
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...